What is the Fuji Pharma Co., Ltd. stock price forecast?

Fuji Pharma Co., Ltd. is currently trading at ¥2,210. View real-time AI analysis on Alpha Lenz.

What is Fuji Pharma Co., Ltd. insider trading activity?

View the latest insider trading data for Fuji Pharma Co., Ltd. on Alpha Lenz.

What is Fuji Pharma Co., Ltd.'s P/E ratio?

Fuji Pharma Co., Ltd.'s P/E ratio is 18.0.

Fuji Pharma Co., Ltd.

JPX · 4554

¥2,210-46(-2.04%)Market closed

Ask about Fuji Pharma Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Fuji Pharma Co., Ltd. trades at a P/E of 18.0 (fair value) with modest ROE of 6.5%. 3Y revenue CAGR of 13.4% highlights clear growth momentum.”

Ask for details →

Company Overview

Fuji Pharma Co., Ltd. is a prominent player in the pharmaceutical sector, specializing in the development, production, and sale of prescription drugs. Established in Japan, the company is renowned for its focus on women's health, actively manufacturing a range of gynecological and obstetric medications. Apart from women's health, they also provide treatments in areas such as cancer, dermatology, and antibiotics. Known for their sophisticated research and development capabilities, Fuji Pharma strives to advance healthcare solutions by fostering innovation and enhancing drug efficacy and safety. The company's contributions are vital within the healthcare ecosystem, impacting hospitals, clinics, and pharmacies by ensuring the availability of essential medicines. With its dedication to improving patient outcomes and its substantial role in pharmaceuticals, Fuji Pharma Co., Ltd. continues to reinforce its presence in both domestic and international markets, underlining its commitment to health and wellness.

CEOShuhei Morita

Websitehttps://www.fujipharma.jp

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees1,658

Company Statistics

FY 2025

Profile

¥53,928,744,870Market Cap

¥51,677,000,000Revenue

0.00Shares Out

1,658Employees

Margins

40.18%Gross

17.48%EBITDA

9.66%Operating

7.74%Pre-Tax

5.81%Net

Valuation

17.98P/E

1.15P/B

1.04EV/Sales

8.59EV/EBITDA

27.70P/FCF

Growth (CAGR)

13.41%Rev 3Yr

8.87%Rev 5Yr

9.72%Op Inc 3Yr

9.70%Op Inc 5Yr

3.61%Net Inc 3Yr

7.55%Net Inc 5Yr

Returns

3.27%ROA

6.49%ROE

4.72%ROIC

Financial Health

¥7,245,000,000Cash & Cash Equivalents

¥39,255,000,000Net Debt

99.14%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Fuji Pharma Co., Ltd. trades at a P/E of 18.0 (fair value) with modest ROE of 6.5%. 3Y revenue CAGR of 13.4% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Fuji Pharma Co., Ltd. (ticker: 4554) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,658 employees. Market cap is $53.9B.

The current price is 2,210 with a P/E ratio of 17.98x and P/B of 1.15x.

ROE is 6.49% and operating margin is 9.66%. Annual revenue is $51.7B.